These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32781946)

  • 1. Key questions for modelling COVID-19 exit strategies.
    Thompson RN; Hollingsworth TD; Isham V; Arribas-Bel D; Ashby B; Britton T; Challenor P; Chappell LHK; Clapham H; Cunniffe NJ; Dawid AP; Donnelly CA; Eggo RM; Funk S; Gilbert N; Glendinning P; Gog JR; Hart WS; Heesterbeek H; House T; Keeling M; Kiss IZ; Kretzschmar ME; Lloyd AL; McBryde ES; McCaw JM; McKinley TJ; Miller JC; Morris M; O'Neill PD; Parag KV; Pearson CAB; Pellis L; Pulliam JRC; Ross JV; Tomba GS; Silverman BW; Struchiner CJ; Tildesley MJ; Trapman P; Webb CR; Mollison D; Restif O
    Proc Biol Sci; 2020 Aug; 287(1932):20201405. PubMed ID: 32781946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
    Brett TS; Rohani P
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25897-25903. PubMed ID: 32963094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: test, trace and isolate-new epidemiological data.
    Brüssow H
    Environ Microbiol; 2020 Jul; 22(7):2445-2456. PubMed ID: 32510748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies.
    Di Domenico L; Pullano G; Sabbatini CE; Boëlle PY; Colizza V
    BMC Med; 2020 Jul; 18(1):240. PubMed ID: 32727547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of coordinated COVID-19 exit strategies across Europe.
    Ruktanonchai NW; Floyd JR; Lai S; Ruktanonchai CW; Sadilek A; Rente-Lourenco P; Ben X; Carioli A; Gwinn J; Steele JE; Prosper O; Schneider A; Oplinger A; Eastham P; Tatem AJ
    Science; 2020 Sep; 369(6510):1465-1470. PubMed ID: 32680881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling insights into the COVID-19 pandemic.
    Meehan MT; Rojas DP; Adekunle AI; Adegboye OA; Caldwell JM; Turek E; Williams BM; Marais BJ; Trauer JM; McBryde ES
    Paediatr Respir Rev; 2020 Sep; 35():64-69. PubMed ID: 32680824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study.
    Panovska-Griffiths J; Kerr CC; Stuart RM; Mistry D; Klein DJ; Viner RM; Bonell C
    Lancet Child Adolesc Health; 2020 Nov; 4(11):817-827. PubMed ID: 32758453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus reinfections: three questions scientists are asking.
    Ledford H
    Nature; 2020 Sep; 585(7824):168-169. PubMed ID: 32887957
    [No Abstract]   [Full Text] [Related]  

  • 10. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
    Laxminarayan R; John TJ
    Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of modelling in COVID-19 policy development.
    McBryde ES; Meehan MT; Adegboye OA; Adekunle AI; Caldwell JM; Pak A; Rojas DP; Williams BM; Trauer JM
    Paediatr Respir Rev; 2020 Sep; 35():57-60. PubMed ID: 32690354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
    J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
    [No Abstract]   [Full Text] [Related]  

  • 13. Herd Immunity: Understanding COVID-19.
    Randolph HE; Barreiro LB
    Immunity; 2020 May; 52(5):737-741. PubMed ID: 32433946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Forecasting the Pandemic: The Role of Mathematical Models].
    Gomes MC; Nunes A; Nogueira J; Rebelo C; Viana J; Rozhnova G
    Acta Med Port; 2020 Nov; 33(11):713-715. PubMed ID: 33160432
    [No Abstract]   [Full Text] [Related]  

  • 15. Should Schools Reopen Early or Late? - Transmission Dynamics of COVID-19 in Children.
    Kuttiatt VS; Menon RP; Abraham PR; Sharma S
    Indian J Pediatr; 2020 Sep; 87(9):755-756. PubMed ID: 32542488
    [No Abstract]   [Full Text] [Related]  

  • 16. Proposed strategies for easing COVID-19 lockdown measures in Africa.
    Kitara DL; Ikoona EN
    Pan Afr Med J; 2020; 36():179. PubMed ID: 32952823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Containment strategies for the 2019 Novel Coronavirus: flatten the curve or crush it?
    Killeen G
    Eur J Epidemiol; 2020 Aug; 35(8):789-790. PubMed ID: 32601818
    [No Abstract]   [Full Text] [Related]  

  • 18. The false promise of herd immunity for COVID-19.
    Aschwanden C
    Nature; 2020 Nov; 587(7832):26-28. PubMed ID: 33087872
    [No Abstract]   [Full Text] [Related]  

  • 19. A guide to R - the pandemic's misunderstood metric.
    Adam D
    Nature; 2020 Jul; 583(7816):346-348. PubMed ID: 32620883
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 herd immunity: where are we?
    Fontanet A; Cauchemez S
    Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.